ISETHIONATE SALT OF CDK4 SELECTIVE INHIBITOR Russian patent published in 2008 - IPC C07D471/04 A61P35/00 A61P31/12 C07D213/00 C07D239/00 

Abstract RU 2317296 C2

FIELD: organic chemistry, medicine, biochemistry.

SUBSTANCE: invention relates to 6-acetyl-8-cyclopentyl-5-methyl-2-(5-piperazine-1-ylpyridin-2-ylamino)-8H-pyrido[2,3-d]pyrimidine-7-one isethionate salt and to its crystalline forms. These substances show properties of selective inhibitor of cyclin-dependent kinase 4 (CDK4) and can be used in treatment, for example, of inflammatory and cellular proliferative diseases. Crystalline forms of salt show powdery roentgenogram in values 2θ about 8.7, 13.5 and 17.6 (form A); 5.1, 11.8, 12.1, 12.8, 13.1 and 14.7 (form B), and 8.4, 8.9 and 21.9 (form D). Also, invention relates to methods for preparing crystalline 6-acetyl-8-cyclopentyl-5-methyl-2-(5-piperazine-1-ylpyridin-2-ylamino)-8H-pyrido[2,3-d]pyrimidine-7-one isethionate salt, to medicinal agent and its using for preparing a medicinal agent.

EFFECT: valuable medicinal and biochemical properties of compound.

23 cl, 5 tbl, 18 dwg, 12 ex

Similar patents RU2317296C2

Title Year Author Number
SOLID FORMS OF SELECTIVE CDK4/6 INHIBITOR 2014
  • Chekal Brian Patrick
  • Ide Nathan D.
RU2619944C2
PHARMACEUTICAL COMBINATIONS 2014
  • Ferretti Stefan
  • Zhee Sebasten
  • Khelajlovik Ensar
  • Li Fan
  • Van Khoj-Tsin
RU2684106C2
COMBINATION INCLUDING CYCLIN-DEPENDENT KINASE 4 INHIBITOR OR CYCLIN-DEPENDENT KINASE 6 INHIBITOR (CDK4/6) AND mTOR INHIBITOR FOR TREATING CANCER 2011
  • Borland Mariya
  • Brejn Kristofer Tomas
  • Doshi Shivang
  • Kim Sunkiu
  • Ma Tszyango
  • Merti Dzhosh
  • Chzhan Khun
RU2589696C2
ANTIPROLIFERATIVE AGENTS FOR THE TREATMENT OF PAH 2020
  • Bhattacharya, Samit Kumar
  • Behenna, Douglas Carl
  • Cameron, Kimberly O.
  • Chen, Ping
  • Curto, John M.
  • Freeman-Cook, Kevin Daniel
  • Jalaie, Mehran
  • Kania, Robert Steven
  • Lian, Yajing
  • Nair, Sajiv Krishnan
  • Palmer, Cynthia Louise
  • Pettersson, Martin Youngjin
  • Rui, Eugene Yuanjin
  • Sammons, Matthew Forrest
  • Yang, Qingyi
  • Zhang, Liying
RU2786588C1
COMBINATION THERAPY FOR TREATMENT OF MAMMARY GLAND CANCER 2018
  • Karr, Craig D.
  • Korpal, Manav
  • Rioux, Nathalie
  • Smith, Peter Gerard
RU2764724C2
(1S,2S,4R)-4-{4-[(1S)-2,3-DIHYDRO-1H-INDEN-1-YLAMINO]-7H-PYRROLO[2,3-d]PYRIMIDIN-7-YL}-2-HYDROXYCYCLOPENTYL)METHYL SULPHAMATE HYDROCHLORIDE 2010
  • Armitehjdzh Ian G.
  • Chopra Reenu
  • Kuper Martin Ian
  • Lehngston Mehriann
  • Lehngston Stefen P
  • Viskochil Stepan
RU2562245C2
DERIVATIVES OF PYRIDOPYRIMIDINES, METHODS FOR THEIR PREPARING AND PHARMACEUTICAL COMPOSITION BASED ON THEREOF 2002
  • Chen' Jan' Dzheffri
  • Dann Dzhejms Patrik
  • Goldshtejn Dejvid Majkl
  • Shtal' Kristof Martin
RU2269527C2
HYDROXYLATED AND METHOXYLATED CYCLOPENTA[B]PYRIMIDINES AS PROTEIN KINASE INHIBITORS 2007
  • Mitchell Jan S.
  • Blehjk Dzhejms F.
  • Ksu Rui
  • Kallan Nikolas K.
  • Ksiao Dengming
  • Spenser Kit Li
  • Benksik Jozef R.
  • Liang Dzun
  • Safina Brajan
  • Chzhang Birong
  • Chabot Kristin
  • Do Stiven
  • Uolles Ilaj M.
  • Behnka Anna L.
  • Shlekhter Stiven T.
RU2478632C2
CERTAIN PROTEIN KINASE INHIBITORS 2015
  • Wang Weibo
  • Zhao Xingdong
  • Li Tongshuang
  • Tian Qiang
  • Zhang Huajie
  • Tan Haohan
  • Wang Xianlong
  • Liu Qihong
  • Li Zhifu
  • Zhang Weipeng
  • Chen Zhifang
  • Jiang Lihua
  • Liu Yanxin
  • Linghu Li
  • Lin Min
  • Sun Jing
RU2671494C2
NEW POLYMORPHS OF CALCIUM SALT AS ANTI-INFLAMMATORY, IMMUNOMODULATORY AND ANTI-PROLIFERATING AGENTS 2019
  • Vitt, Daniel
  • Muehler, Andreas
  • Groeppel, Manfred
  • Kohlhof, Hella
RU2797511C2

RU 2 317 296 C2

Authors

Bejlin Vladimir Genukh

Blehkbern Ehntoni Klajd

Ehrdman Dehvid Tomas

Tugud Peter Lourens

Dates

2008-02-20Published

2004-06-28Filed